Hims & Hers Health is testing peptide ingredients including BPC-157 ahead of an expected FDA decision on compounding, and expects gross margins to remain below historical levels due to international and weight-loss expansion.
FirstSquawk08/11, 04:43 AM
Related assets
Coming up for HIMS
Explore next
Latest HIMS news
ZeroHedge08/11, 07:07 PM
FirstSquawk08/11, 03:13 AM
Finnhub07/30, 06:00 AM